ANI Pharma Inc Development Agreements

3 Contracts & Agreements

Recent Contracts

LibiGel once daily transdermal testosterone gel in Phase III development for treatment of female sexual dysfunction (FSD) (Filed With SEC on March 17, 2008)
LibiGel once daily transdermal testosterone gel in Phase III development for treatment of female sexual dysfunction (FSD) (Filed With SEC on March 17, 2008)
LibiGel once daily transdermal testosterone gel in Phase III development for treatment of female sexual dysfunction (FSD) (Filed With SEC on March 17, 2008)